Proteins

Olon Opens New Proteins Manufacturing Site in Italy

Olon Biotech, a division of Italian API producer Olon, has inaugurated a new facility for the industrial-scale production of proteins from alternative sources at its site in Settimo, Italy. Olon pegged the investment in the new plant at €70 million.

News

Germany’s Merck Buys Erbi Biosystems

Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The company is based in the US state of Massachusetts.

Whitepaper

ExpreS2ion Biotechnologies and Oxford's Jenner Institute Enter Licensing Agreement

News

Nomad Receives €1.2 Million Grant from Saxony-Anhalt

Topics

Therapeutic Proteins: Strategies to Modulate Their Plasma Half-lives

Topics • Chemistry

Chemical Distribution: Three Attractive Markets

Topics • Chemistry

Sustainability All Along The Value Chain

News

DSM Biologics to Acquire Rhobust Technology from Upfront Chromatography

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Interview

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.